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A cosmid clone containing the gene for mouse chromogranin B (secretogranin I), a secretory protein found in secretory granules of most endocrine 
cells and neurons, was isolated and sequenced. The chromogranin B protein was found to be encoded by 5 exons which correspond to the cleaved 
signal peptide, the short N-terminal sequence preceding the disulfide-bonded loop structure, the disulfide-bonded loop structure itself, the large, 
variable region comprising -90% of the protein, and the conserved C-terminal sequence. The promoter region of the chromogranin B gene is very 
GC-rich and contains a CATAA motif, a CAMP-responsive lement and an Spl binding site. 
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1. INTRODUCTION 
The chromogranins/secretogranins (Cgs/Sgs) are a 
family of acidic secretory proteins [ 1,2]. A remarkable 
feature of these proteins is their occurrence in secretory 
granules of most peptidergic endocrine cells and 
neurons [1,2], which is more widespread than that of 
any known peptide hormone and neuropeptide. The 
Cgs/Sgs have therefore increasingly been used as 
markers of normal and neoplastic neuroendocrine cells 
(for reviews, see [3]). The molecular basis of the 
widespread, yet exclusively neuroendocrine, expression 
of these proteins is unknown. 
Cgs/Sgs. This may be partly due to the lack of an ap- 
propriate animal model which allows the manipulation 
of not only the extracellular but also the intracellular 
levels of these proteins. 
The physiological function(s) of the Cgs/Sgs re- 
main(s) to be established. Proposed functions include 
roles as: (i) precursors of biologically active peptides, in 
particular of those modulating regulated protein secre- 
tion in an autocrine and/or paracrine fashion [4-61; (ii) 
modulators of the proteolytic processing of peptide 
hormone and neuropeptide precursors [7,8]; and (iii) 
helper proteins in the packaging of certain peptide hor- 
mones and neuropeptides into secretory granules and in 
the organisation of the secretory granule matrix [1,9]. 
Although in vitro data consistent with these roles have 
been reported [6,8,10-121, there is no direct in vivo 
evidence establishing a physiological role of the 
During the past 4 years, the primary structure of the 
3 established members of this protein family, chro- 
mogranin A (CgA) [13,14], chromogranin B (secreto- 
granin I) (CgB) [15,16] and secretogranin II (SgII) 
[ 11,171, has been deduced from the sequences of cloned 
cDNAs. The comparison of the primary structure of 
these proteins revealed that CgA and CgB are more 
closely related to each other than either protein is to 
SgII [ 11,15,16]. In particular, CgA and CgB contain a 
homologous, disulfide-bonded loop structure near their 
N-termini and another homologous sequence at their C- 
termini [15,16]. In either protein, these two homol- 
ogous domains are highly conserved despite con- 
siderable interspecies equence variation in the remain- 
ing, major portion of the molecule. The protein se- 
quence of both pre-CgA and pre-CgB appeared to con- 
sist of 5 parts: (i) a cleaved signal peptide; (ii) a short N- 
terminal sequence preceding the disulfide-bonded loop 
structure; (iii) the disulfide-bonded loop structure itself; 
(iv) a large, variable region; and (v) the conserved C- 
terminal sequence [151. 
Correspondence address: W.B. Huttner, Cell Biology Programme, 
European Molecular Biology Laboratory, Postfach 10.2209, D-6900 
Heidelberg, FRG 
Abbreviations: Cgs/Sgs, chromogranins/secretogranins; CgA, 
chromogranin A; CgB, chromogranin B; SgII, secretogranin II; CRE, 
CAMP-responsive element 
It would therefore be of interest o relate the sequence 
of these proteins to the exon-intron organization of the 
respective genes. The isolation and characterization of 
these genes would also be a first step towards 
understanding their expression and would provide the 
tools to investigate their function(s) in vivo. We present 
here the first report on the genomic organisation of a 
member of the Cg/Sg protein family, mouse CgB. 
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2. MATERIALS AND METHODS 
2.1. Cloning of the mouse CgB gene 
A cosmid library of 129/svSLcp mouse DNA was screened with a 
rat CgB cDNA probe [la], and positive clones were isolated and 
characterised further as described [18] including fine mapping of 
restriction enzyme sites. The orientation of the mouse CgB gene was 
determined by differential hybridization of DNA fragments pecific 
for the 5’ or 3’ part of the rat CgB cDNA on Southern blots of 
cosmid DNA digested with various restriction enzymes. 
2.2. Sequence analyses 
tron 1 (aagCTGTCAG, fig.lB), CAG rather than aag 
serves as acceptor site; with respect to the 5 ’ donor 
splice site of intron 1, this would predict that in the se- 
quence Ggtgagtg (Fig. 1B) the second gtg would serve as 
donor site to retain the open reading frame. This alter- 
native would result in a 19-residue signal peptide ending 
with -GDS (rather than -AVSS, see fig.2), with -D- be- 
ing encoded by both exons 1 and 2, but would not affect 
the amino acid sequence downstream of the putative 
signal peptidase cleavage site.) 
The sequences of the promoter region, all exons and most parts of 
the introns were obtained by subcloning of restriction fragments into 
suitable vectors and sequencing using the dideoxy-chain-termination 
method. 
2.3. Primer extension 
Primer extension analysis was performed as described [19], using 
an oligonucleotide complementary to positions +50 to +69 of the 
mouse CgB gene (see fig.lB). RNA was isolated from mouse AtT-20 
cells and mouse liver by standard procedures. 
3. RESULTS AND DISCUSSION 
3.1. Cloning and sequencing of the mouse CgB gene 
When the human CgB cDNA [15] and the rat CgB 
cDNA [16] (kindly provided by Dr G. Sutcliffe) were 
used as probes on mouse genomic Southern blots, only 
the rat probe gave a clear signal (data not shown). The 
presence of single hybridizing fragments after digestion 
of mouse genomic DNA with various restriction en- 
zymes suggested that mouse CgB is encoded by a single 
gene. Screening of an (amplified) mouse cosmid library 
led to the identification of 8 clones which were found to 
be identical by mapping of restriction enzyme sites. 
Further mapping of one of these clones (mcSgI-9c, 
fig. 1A) using 12 different restriction enzymes uggested 
that it contained the complete mouse CgB gene. 
The small exon 2 encodes (besides the end of the 
signal peptide) all except the last 3 residues of the short 
N-terminal sequence which precedes the disulfide- 
bonded loop structure (fig.2) [ 151. The latter and a fur- 
ther 6 residues, including the first dibasic site, are en- 
coded by exon 3. The large exon 4 encodes essentially 
the entire variable region of CgB which comprises 
-90% of the mature protein. Finally, exon 5 encodes 
the last dibasic site and the conserved C-terminal do- 
main [ 151, and in addition specifies the 3 ’ -untranslated 
region of the mRNA including the polyadenylation 
signal (fig.lB). 
The major conclusion that can be drawn from these 
data is the remarkable correspondence between the 
previously suggested [ 151 domain structure of the CgB 
protein sequence and the organisation of the CgB gene 
into 5 exons. In particular, the fact that the disulfide- 
bonded loop structure and the C-terminal portion of 
CgB are each encoded by separate exons strongly sug- 
gests that these domains are indeed distinct units with 
presumably important, though as yet unknown, roles in 
the structure and function of this protein. 
To determine the exon-intron structure of this gene, 
restriction fragments containing CgB sequences, as 
identified by Southern blot analysis using the rat CgB 
cDNA as probe, were subcloned and sequenced as 
shown in fig.lA. The comparison of the nucleotide se- 
quence with that of the rat CgB cDNA [ 161 allowed the 
definition of the exon-intron boundaries (fig. 1B) which 
were consistent with the established consensus rules for 
donor and acceptor splice sites. The mouse CgB gene 
without the promoter region is - 12.1 kb long and is 
comprised of 5 exons and 4 introns (fig.lA,B). The 
length of the exons ranges from 47 bp (exon 2) to 1766 
bp (exon 4), and that of the introns from 0.4 kb (intron 
2) to 5.4 kb (intron 3). The 5 exons predict an open 
reading frame of 2031 nucleotides, encoding a protein 
of 677 residues. 
3.3. Species comparison of the chromogranin B protein 
sequence 
A comparison of the predicted protein sequence of 
3.2. Relationship between exons and protein sequence 
mouse CgB with that of human [15] and rat [16] CgB is 
shown in fig.2. Confirming and extending previous 
observations [15,161, the N- and C-terminal regions of 
this protein are highly conserved between species and 
are homologous to the corresponding regions in CgA. 
In contrast, the bulk of mouse CgB, between the 
disulfide-bonded loop structure and the conserved C- 
terminal domain, shows a remarkable degree of se- 
quence variation not only to the corresponding human 
protein, but even to another rodent, rat, CgB. The 
tyrosine sulfation site previously identified in human 
[15] and rat [ 161 CgB is conserved in the mouse protein 
(Tyr-328) and is thus presumably biologically signifi- 
cant. In contrast, neither the -RGD- sequence at posi- 
tion 157-159 of rat CgB [16] nor the potential N- 
glycosylation site at position 278 of mouse CgB are con- 
served. 
Exon 1, besides pecifying the 5 ’ -untranslated region Mouse CgB contains 18 sites of two or more adjacent 
of the mRNA (62 nucleotides, fig. lB), encodes most of amino acids (fig.2). 13 of these sites, including the 11 C- 
the signal peptide of pre-CgB (fig.2). (It cannot be ex- terminal ones, are conserved in sequence position be- 
cluded that concerning the 3 ’ acceptor splice site of in- tween mouse, rat and human CgB; 2 sites are slightly 
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gcccaccgcgccaCAGCTGCTCTGCGGAGCCCGCACCCGCCGAGCTCCTCCTACACTCAGCT PCGGCTATG 
CTCCTCGGCCTC~TGGGCGCAGCGG~TCTGGCCGgtgagtgggatt .*..*.~***...‘~~*.~,.~~.~,*....~....,,..‘*.. 
(intron 1: 3.5 kbl........ *..*..*~.~~~.,.‘**....*~*~*.~**.*~..*.*...,*~.~,....*..~....‘..* 
tctccttcaaagCTGTCAGCTCAGCTCCAGTGGATAACAGGGATCACAATGAAG~ATGgtaagttgagat ................... 
(intron 2: 0.4 kb) ........................................................................ 
gtcttctcatagGTGACTCGCTGCATTATCGAAGTCCTCTCAAATGCCCTATC~~GTCCAGTGTTCCAACGATCACCCCTGAGTGCCGG 
CAAGTCCTG~GAAGAgtaagtgtctca . . . . . . ..‘*~~..*f.~.*....**~*I*.*..*~~.*.*‘*.....**~*~**.**..*. 
(intron 3: 5.4 kb) ..~...~..,*,...~,~‘*.....‘~....*~~.***,...*~..,........*.“.*......,...* 
ttttcattatagGTEGAAAAGAGGTCAAAGGTGAAGAGAAAGGTGAAAACTACGGTTGCTAAGAGACCCAG 
CCGATGCCTCAGGAACCCGCTGGGCCTCCAGTAGGGAGGATGCAGGCGCTCCAGTAGAAGACTCTCAAGGCCAGACG~GGTAGGCAATG 
AGAAGTGGACAGAAGGAGGAGGACACAGCCGAGAGGGAGTGGATGATC~GAGAGTCTCCGTCCCTCC~CC~CAAGCGTCCAAAGAAG 
CAAAGATATACCATTCGGAAGAGAGGGTGGGAAAGAGAGGGAGAAAGAAGAAGGCAAGATTTACCCAATGGGGGAGCACAGGGAAGATG 
CTGGTGAAGAGRAGRAACACATTGAAGATTCTGGAGAGAAGCCGAACACCTTCTCCRACAACA~G~GCGAGGCTTCCGCTAAG~~AG 
ATGAGTCAGTGGCCAGAGCAGATGCACACACTCCATGGAGCTGGAGGAG~GACACACAGTA~GAGCA~GCAGCCAGGAGAGTGGAGAGG 
AGACAAGGAGGCAGGAGAAACCCCAGGAGCTTACCGACCAGGACCAGAGCCAGG~GAATCCCAGGAAGGCGAGGAAGGTGAGGAAGGCG 
AGGAAGGCGAGGAAGGCGAGGAAGACTCAGCCTCTGAAGTAACCRRACGCAGGCCCAGACACCACCACGGGAGAGCGGGTCCAACAAGT 
CCTCTTACGAAGGGCATCCTCTATCTGAGGAAAGGAGAGACCCTCTCCC~GGAGTCCAAGGAGGCAGATGTGGCCACAGTCCGTTTAGGGG 
AAAAAAGGAGTCACCATCTAGCTCACTACAGGGCTTCAGAAG~G~CCTGAATATGGGG~GAATCGAG~GCTATCGGGGACTACAGT 
ACCGGGGTAGAGGAAGCGAAGAGGACAGAGCCCCAAGGCCTCGGAGTGAGGAGAGTCAGG~GGGAGTATAAGAGAAACCACCCCGACT 
CTGAACTGGAAAGCACAGCAAACRGACAGACATGGTGAAG~A~~GAGG~GAGAGGAGCTACGAGGGGGC~TGGACGCC~CACAGAGGCA 
GGGGGCGGGAGCCAGGAGCCCATTCTGCTCTTGACACCAGAG~G ~ G~TCTTGGATG~GG~ACTACC~TGTTCGCGA~GCC 
CAATAGATACGGCAAAAAGGTACCCACAAATGGCRCTCAACTATGGCGAGGAAGGGGACCAAGGGA 
GATGGTGGCAGCAGGAAGAGCAGCTAGGACCGGAAG~AGCAGGGAGG~GTAAGGTTTCCAGACAGACAATATGAGCCCTATCCCATCA 
CTGAAAAGAGGAAGAGGTTAGGGGCGCTGTTCAACCCGTACTTTGACCCTCTCCAGTGGAAGAATAGTGACTTTGAGAAAAGAGGCAACC 
CAGATGACAGTTTTCTTGAGGATGAAGGTGAAGACAGAAATGGGGTGACCTTGACTGAGAAGAATTCCTTCCCAGAGTACAACTATGACT 
GGTGGGAGAGAAGGCCCTTCTCAGAGGATGTGAATTGGGGATATGAG~GAGAA~TTTGCCAGGGCCCCTCAGCTCGACTTGAAACGGC 
AATATGATGGAGTGGCCGAGTTGGACCaGCTGCTGCTATCGGAGGAGCAGA 
TGGGGCCTCACCAGGAGGCAACGATGAAAAGGCCRGGCCAGGGCTGACCAGAGAGTTCTGACGGCGGAAGAGgtacggtttg............ 
(intron 4: 0,s kb) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..‘...... 
* 
tttctgtttcccagAAAAAGGAACTGGAGAACTTGGCTTGGCTGCGATGGATCTGGAACTCCAGAAGATAGGGGAAAAGTTCAGCCAGCGGGGCT 
GACAGTTGGAGAGACGAGCCTTTCACTGAAGGACACCATTGATTCACCCACAGGCAGAAAGCAGAA~~~ACTGTTTATTAAATGTTTGAT 
GCAGTTGGAAATATCATTTATCTTTGCCAGAATGCTAATGCCATGTGACTAGCGTGACTTGTAGCGTATTCTTCCTGCAAAATAGATGTT 
TCACGTGTCTGTGACAATGACCGTGTTACTGTTGTTGAAACACAAAC~TA~AAGATTTACCTGAAACaaagtccttttt......... 
n*r\nrrn 
Fig. 1. The mouse CgB gene. (A) Localisation of exons l-5 on the cosmid mcSgIdc containing the mouse CgB gene. The sites of three restriction 
enzymes (B = BgfI; E = EcoRI; S = MI) as well as the orientation and length of the individual DNA sequences obtained (arrows) are indicated. 
(B) DNA sequence of exons 1-5 (capital etters) and of portions of the introns and the 5’ and 3’ adjacent sequences ( mall letters) of the mouse 
CgB gene. For the 5’ end of exon 1, see figs. 3 and 4. The 3’ end of exon 5 is defined by comparison with the 3’ end of the rat CgB mRNA [16]. 
The lengths of the 4 introns are indicated. The oBgonucl~tide used for primer extension (see fig.3) was ~mpiement~ to the underIined 
nucleotides. Asterisks, start and stop codons of translation; open triangles, putative polyadenytation signal. 
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Exon 3 Exon 4 --_ --- 
-20 I * * ++ 
MQPAMLLGLLGAAALAAVSSAPVDNRDHNEEMVTRCIIEVLSNALSKSSVPTITPECRQVLKKSGKEVKGEEKGENQNSKFEVRLLRDPA 
__R___-___________ I_-______-_____________________A----_______R______________~____________S 
___TL__S____VG____N_M_____N___G____-_____________A-P--________T_R_D__DK_TT__E_T___________ 
DASGTRWASSREDAGAPVE.DSQGQTKVGNEKWTEGGGHSREGVDDQE.SLRPSNQQASKEAKIYHSEERVGKEREKEEGKIYPMGEHR 
_--VGR----_-BT-w-v-. __P__A__D_~E__G_______A_____~__H~~~~~V~~~~~~R~~___G___E_E_______K____G 
___~~~~~___~~____~~~~I-_P__~_~-A--_---~--------~~~~Q~--~--~~-~-~-~-~~ ---KSQREDE-E---EN-QK--RG- 
tt tt +++ ++ 
DAGEEKKHIEDSGEKPNTFSNKRSEASAKKKDESV~~S~L.EEKTHSREQSSQESGEETRRQEK.PQELTDQDQSQEESQEGEEG 
tt+ A tt ++ 0 
EEGEEGEEGEEDSASEVTK..PRHHHGRSGSNKSSYEGH.PLSEERRPSPKESKEADVAmRLGEKRSHHLAHYRASEEEPEYGEESR 
___ . . . . . . . . . ~~_______~~_____~_~Q__-~~~~~~------KHAAG---D_N~~~~~~~~~~~~~~~~_____________~____~_ 
. . . . . . . . . . . -AT---D---TR--------RPDR--QG-SL-.---KGHPQE--E-SN-SMAS -----D--ST----__-------_IK 
tt 
SYRGLQ......... YRGRGSEEDRAPRPRSEESQEREYKRNHPDSELESTANRH 
--P-F-APQGLQ... ________V___S-___---_K______------------ S__________-_K_--_________-YP___S_Q 
G-P-V-APEDLEWER---_----Y_----Q----WDE-D_ ---S----GL-PGK--H-____G__R_YFMS-_____ 
++ . . . . . . . . . . . . . . . . . . . ..I . . . . . . . . . . . . . . . . . . . . . . . . . ...++ . . . . . . . . . . . . _ . . . . . . . . . . . . I . . . . _ . . . . . . . . I. “am” . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . I.” . . . . . . . . . . ...” . . . . . . . . . . _ . . . . . . . . . . . . . I . ...” . . . . . . _ . . . . . . ++++ 
EKRLLDEGHYPVRESPIDTAKRYPQSKWQEQEKNYLGEEGDQGRWWQQEEQLGPEES~EV~PDRQYEPYPITEKRRRLGALFNPYF 
_________D__H___V_----- ______G-GB-----D---------- -----B----____S______A___T_______________ 
__-F-G---HR-Q-NQM-K-R-H--GA-K_LDR- --------AP-K-Q--GDLQDTK-N---A--Q-K--SSH~TA_______E_____y 
F-G-T-HR-Q--QR-K-R-RLPG...-L.R---D----VGEEAARGV 
tt tt tt t+ 
DPLQWKNSDFEKRGNPDDSFLEDEGEDRNGVTLTEKNSFPEY~D~~~FSED~GYEKRSFA~Q~L~QYD.GVAELDQLLHY 
____________K________D_D___G____M____F__________K__---____________K__H________D___________ 
_____-S-H--R-D-MN-N--.. ___EE_EL__N___F__________KK__-__________NL__V_K________.R__Q_______ 
NL..D-K----__--.R_-_--___T_ 
-- Exon 4 Exon 5 ___--- 
ttt........................................................................... "CCB II................. +t ........................................................ 
RKKADEFPDFYDSEEQMGPHQEANDEKARADQRVLTABEKKELENLAAMDLELQKIABKFSQRG 
____A__________________E___D______--E-_-~~-~~~~~~~~~~~~~~--~---- 
___SA__________PVST____EN-_D__D__-ED_-~~-_~~~~~~~~----~~------ 
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Fig.2. Relationship between exons and primary structure of mouse CgB and comparison of the mouse (mCgB), rat (rCgB) [16] and human (hCgB) 
[15] protein sequences. Gaps introduced for aligning the sequences are indicated by dots. Amino acid residues in rCgB and hCgB identical to the 
corresponding residues in mCgB are shown as dashes. Numbers on the right refer to the sequences positions of the respective mature, secretory 
protein; - 20, beginning of signal peptide; 1, N-terminus of mature, secretory protein. *, cysteine residues; + , sites with two or more adjacent 
basic amino acid residues; A , potential N-glycosylation site; circled S, tyrosine sulfation site. The positions of the human CgB-derived peptides 
‘GAWK’ [20,21] and ‘CCB’ [21] are indicated by the dotted lines. The sequences of peptides isolated from the ovine adrenal medulla (sOA) and 
presumably derived from ovine CgB are also given [21,27,28]. 
shifted in sequence position compared to human CgB, 
and 3 sites are conserved between mouse and rat CgB 
but absent in human CgB. The high degree of conserva- 
tion of the di-, tri- and tetrabasic sites suggests that they 
are significant for the structure and/or the proteolytic 
processing of CgB. However, the question remains 
unanswered whether the presence and conservation of 
these sites suggests that CgB is a precursor of biological- 
ly active peptides. Two observations are worth men- 
tioning in this regard. First, all of the 18 di-, tri- and 
tetrabasic sites are located either within the region en- 
coded by the large exon 4 (16 sites) or directly adjacent 
to it (2 sites). Thus, if CgB should prove to be a precur- 
sor for biologically active peptides, most, if not all, of 
these peptides would be encoded by the same exon. Se- 
cond, the sequence variation between rodent and 
human CgB in the region from which the peptide 
‘GAWK’ [20,21] is derived is quite remarkable and 
222 
higher than one might expect if ‘GAWK’ were a struc- 
turally conserved, biologically active peptide. 
3.4. The mouse CgB promoter 
To define the mRNA initiation site and subsequently 
the DNA sequence containing the CgB promoter, a 
primer extension experiment was performed. As shown 
in fig.3, a specific extension product was obtained only 
with RNA from AtT-20-cells (lane l), a mouse neuroen- 
docrine cell line which expresses CgB (data not shown), 
but not with RNA from mouse liver (lane 3), a non- 
neuroendocrine tissue. The same oligonucleotide used 
for primer extension was also used to sequence the 
mouse CgB DNA. Side-by-side analysis of the products 
of the primer extension and sequencing reactions on the 
same gel allowed the identication of the 5’ end of the 
mouse CgB mRNA as the nucleotide located 62 residues 
upstream of the ATG (fig.lB). 
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GATC1234 
Fig.3. Mapping of the CgB mRNA start site by primer extension 
analysis. A labelled oligonucleotide, complementary to the nucleotide 
sequence from + 50 to + 69 (see fig. l), was annealed to 10 /rg RNA 
from AtT-20 cells (lane l), to 1 pg RNA from mouse liver (lane 2). to 
10 /cg RNA from mouse liver (lane 3), or to 10 ~8 of tRNA (lane 4). 
To determine precisely the endpoint of extension, a DNA sequencing 
reaction was performed with the same oligonucleotide and analysed 
on the same polyacrylamide gel. The endpoint of extension is in- 
dicated by the arrow. 
The region preceding the mRNA initiation site 
(marked + 1 in fig.4) shows notable features. First, the 
215 bp sequence shown in fig.4 is very GC-rich (75%). 
-21s GATCTACAGC ACCTGGCGTC CCCGCATCCC TGCCCGTGCC TGCTGGGACC 
-134 
-165 CTGCGCMGG CCGULCACAC TGGCTGTGCT TCCGCCCGCT GGCGCCGCCT 
-102 
-115 CGGGGCTGm CCGTGACGTC AGGGTCTGAG CGAGGGGCGC CCCAGTCGCC 
-31 
-65 GCTCGCCCCC GGGTACTGCA CCCCGCCTGC CCTTWG AGCCAGGCCT 
+I 
-15 GCGCCCACCG CGCCACAGCT GCTCTGCGGA GCCGC.... I 
Fig.4. The mouse CgB promoter egion. 215 base pairs of the putative 
mouse CgB promoter region are shown. The position + 1 and the ar- 
row indicate the mRNA initiation site, determined by primer exten- 
sion (see fig.3). Typical promoter elements such as TATA box 
(CATAA, position -311, CRE box (TGACGTCA, position - 102) 
and Spl box (CCGCCC, position - 134) are underlined. 
Second, consistent with the typical distance of about 30 
bp between mRNA start site and TATA box, a CATAA 
sequence similar to that found in the @globin gene 1221 
is present at position - 3 1. Third, a CAMP-responsive 
element (CRE box) [23] and an inverted binding site for 
the Spl transcription factor [23] are found at positions 
- 102 and - 134, respectively. Other known binding 
sites for transcription factors could not be identified. 
The presence of these elements uggests a functions 
promoter in this region. It is worth noting that the CRE 
box is present in the promoters of several other genes 
known to be expressed in neuroendocrine cells, such as 
parathyroid hormone [24], proenkephalin A [25] and 
somatostatin [26]. Since these genes are inducible by 
CAMP [26], it is tempting to speculate that the expres- 
sion of mouse CgB may be stimulated by those ex- 
tracellular factors that increase intracellular CAMP 
levels. A further comparison of these promoters shows 
that besides the CgB promoter, only the parathyroid 
hormone promoter contains an Spl binding site and 
none contains the TATA box in the form of a CATAA 
motif. In addition, we have noticed a correlation be- 
tween the GC content of these promoters and the 
broadness of expression of these genes, the promoter of 
the proenkephalin A gene, which is expressed in a varie- 
ty of endocrine cells and neurons, had a higher GC con- 
tent (75%) than that of the parathyroid hormone gene 
(37Vo), which is expressed more selectively. It will be in- 
teresting to test the role of these elements, as well as 
others present in the -4.5 kb of 5’ sequence of the 
cloned mouse CgB gene, in the widespread, yet 
specifically neuroendocrine, expression of CgB. 
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